US Bancorp
ABMD

US Bancorp’s Abiomed Inc ABMD Stock Holding History

US Bancorp’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,288
Closed -$1.54M – 4330
2022
Q3 		$1.54M Buy
6,288
+120
+2% +$32.4K ﹤0.01% 876
2022
Q2 		$1.53M Sell
6,168
-265
-4% -$71.5K ﹤0.01% 919
2022
Q1 		$2.13M Buy
6,433
+2,035
+46% +$626K ﹤0.01% 864
2021
Q4 		$1.58M Buy
4,398
+78
+2% +$26.4K ﹤0.01% 1006
2021
Q3 		$1.41M Buy
4,320
+816
+23% +$276K ﹤0.01% 1025
2021
Q2 		$1.09M Sell
3,504
-373
-10% -$114K ﹤0.01% 1158
2021
Q1 		$1.24M Sell
3,877
-386
-9% -$124K ﹤0.01% 1043
2020
Q4 		$1.38M Buy
4,263
+209
+5% +$57.8K ﹤0.01% 961
2020
Q3 		$1.12M Buy
4,054
+681
+20% +$196K ﹤0.01% 947
2020
Q2 		$815K Buy
3,373
+664
+25% +$133K ﹤0.01% 1047
2020
Q1 		$394K Sell
2,709
-404
-13% -$67.1K ﹤0.01% 1336
2019
Q4 		$531K Buy
3,113
+932
+43% +$173K ﹤0.01% 1340
2019
Q3 		$387K Buy
2,181
+50
+2% +$10.8K ﹤0.01% 1489
2019
Q2 		$554K Sell
2,131
-140
-6% -$37.1K ﹤0.01% 1358
2019
Q1 		$649K Sell
2,271
-1,136
-33% -$378K ﹤0.01% 1266
2018
Q4 		$1.11M Buy
3,407
+1,238
+57% +$430K ﹤0.01% 963
2018
Q3 		$976K Buy
2,169
+1,078
+99% +$425K ﹤0.01% 1118
2018
Q2 		$446K Sell
1,091
-1,279
-54% -$463K ﹤0.01% 1492
2018
Q1 		$689K Sell
2,370
-208
-8% -$52.7K ﹤0.01% 1280
2017
Q4 		$483K Sell
2,578
-298
-10% -$55.6K ﹤0.01% 1457
2017
Q3 		$485K Buy
2,876
+1,156
+67% +$175K ﹤0.01% 1427
2017
Q2 		$246K Sell
1,720
-630
-27% -$84.7K ﹤0.01% 1739
2017
Q1 		$294K Sell
2,350
-90
-4% -$10.4K ﹤0.01% 1631
2016
Q4 		$275K Buy
2,440
+1,250
+105% +$145K ﹤0.01% 1652
2016
Q3 		$153K Sell
1,190
-28
-2% -$3.35K ﹤0.01% 1875
2016
Q2 		$133K Sell
1,218
-954
-44% -$94.9K ﹤0.01% 1876
2016
Q1 		$205K Sell
2,172
-870
-29% -$73.4K ﹤0.01% 1676
2015
Q4 		$275K Buy
3,042
+137
+5% +$11.6K ﹤0.01% 1559
2015
Q3 		$270K Sell
2,905
-1,063
-27% -$93.7K ﹤0.01% 1586
2015
Q2 		$261K Sell
3,968
-621
-14% -$41.3K ﹤0.01% 1651
2015
Q1 		$329K Sell
4,589
-673
-13% -$36.5K ﹤0.01% 1564
2014
Q4 		$201K Buy
5,262
+3,971
+308% +$125K ﹤0.01% 1770
2014
Q3 		$32K Buy
1,291
+748
+138% +$18.9K ﹤0.01% 2692
2014
Q2 		$13K Buy
543
+43
+9% +$1K ﹤0.01% 3009
2014
Q1 		$13K Hold
500
– – ﹤0.01% 2978
2013
Q4 		$13K Buy
500
+200
+67% +$4.94K ﹤0.01% 2915
2013
Q3 		$6K Hold
300
– – ﹤0.01% 3010
2013
Q2 		$6K Buy
+300
New +$6.03K ﹤0.01% 2974

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

US Bancorp's ABMD Position: Q4 2022 in Review

US Bancorp sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,288 shares — an estimated $1.54M sold.

US Bancorp first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $2.13M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • US Bancorp reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • US Bancorp sold 6,288 Abiomed Inc shares in Q4 2022, an estimated $1.54M.
  • US Bancorp first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • US Bancorp's Abiomed Inc position peaked at $2.13M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.